The Aβ hypothesis postulates that an imbalance in the production of extracellular Aβ42 plaques by mutations in at least three genes (e.g., APP, PSEN1; PSEN2) is an early initiating factor in AD. This evidence concerns the gene APP and Alzheimer disease.